(Q37761048)

22 August 2017

1 reference

title

Cardioprotective properties of bradykinin: role of the B(2) receptor (English)

1 reference

22 August 2017

Athanasios J Manolis

1

1 reference

22 August 2017

Maria E Marketou

series ordinal

2

1 reference

22 August 2017

Irene Gavras

series ordinal

3

1 reference

22 August 2017

Haralambos Gavras

series ordinal

4

1 reference

22 August 2017

language of work or name

1 reference

27 May 2010

1 reference

22 August 2017

published in

Hypertension Research

1 reference

22 August 2017

volume

33

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

772-777

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2010.82

22 August 2017

exact match

0 references

cites work

Local hormonal factors (intracrine, autocrine, and paracrine) in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

Corcoran Lecture. Angiotensin-converting enzyme inhibition and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

Early onset salt-sensitive hypertension in bradykinin B(2) receptor null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

Effects of renin-angiotensin system blockade in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

Potential role of bradykinin in forearm muscle metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Greene LL, Ferreira SH: Potential screening test for detection of overactivity of renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Relationships between the kallikrein-kinin and prostaglandin systems

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Bradykinin-mediated effects of ACE inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Role of Bradykinin in Insulin Sensitivity and Blood Pressure Regulation During Hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Induction of beta 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Salt-sensitive hypertension in bradykinin B2 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Role of nitric oxide in the control of cardiac oxygen consumption in B(2)-kinin receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Augmentation of Coronary Blood Flow by Ace Inhibition: Role of Angiotensin and Bradykinin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Renal kallikrein-kinin system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Insulin sensitivity, clearance and release in kininogen-deficient rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Role of the B(2) receptor of bradykinin in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Blood pressure and inflammation in apparently healthy men

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Inflammatory markers and the risk of coronary heart disease in men and women

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

C-reactive protein is associated with arterial stiffness in apparently healthy individuals

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

C-reactive protein and arterial stiffness in older adults: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Arterial stiffness is related to systemic inflammation in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Mechanisms Mediating the Vasoactive Effects of the B 1 Receptors of Bradykinin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Increased expression of bradykinin type-1 receptors in endothelium of intramyocardial coronary vessels in human failing hearts

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Regulation of the kinin receptors after induction of myocardial infarction: a mini-review

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Expression of bradykinin receptors in the left ventricles of rats with pressure overload hypertrophy and heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Novel targets of ANG II regulation in mouse heart identified by serial analysis of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

A novel gene (Cmya3) induced in the heart by angiotensin II-dependent but not salt-dependent hypertension in mice.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Angiotensin-converting enzyme regulates bradykinin receptor gene expression

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Upregulation of the cardiac bradykinin B2 receptors after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Upregulation of bradykinin B1-receptor expression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Postconditioning: reduction of reperfusion-induced injury

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Cell signaling, internalization, and nuclear localization of the angiotensin converting enzyme in smooth muscle and endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Angiotensin inhibition and malignancies: a review.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Cardioprotective effects of a selective B(2) receptor agonist of bradykinin post-acute myocardial infarct

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.82

7 January 2021

Identifiers

DOI

10.1038/HR.2010.82

1 reference

22 August 2017

1 reference